Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
gongjin-dan
- Development stage
- Unknown
- Lead developer
- Songjeongo OM Clinic
- Administration
- Oral
01
Overview
Gongjin-dan is a traditional herbal medicine widely used in Korea and China primarily to combat fatigue-related disorders. It has been approved by the Ministry of Food and Drug Safety (MFDS) of the Republic of Korea and is commercially marketed for poor health, fatigue, and fatigue-related disorders. In animal studies, it has demonstrated anti-fatigue, antioxidant, anti-inflammatory, and neuroprotective properties. Clinical evidence suggests it may improve fatigue symptoms by regulating cortisol and other stress hormones, as well as by regulating oxidative stress and immunological activity.
- Brand names
- Gongjin-DanGong Jing DanGongjindan경방공진단
- Other names
- GJD
Beyond the preview
Go deeper on gongjin-dan.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on gongjin-dan.